TY - JOUR T1 - Correction: <em>Type I interferon receptor blockade with anifrolumab corrects innate and adaptive immune perturbations of SLE</em> JF - Lupus Science &amp; Medicine DO - 10.1136/lupus-2018-000286corr1 VL - 5 IS - 1 SP - e000286corr1 A2 - , Y1 - 2018/12/01 UR - http://lupus.bmj.com/content/5/1/e000286corr1.abstract N2 - Casey KA, Guo X, Smith MA, et al. Type I interferon receptor blockade with anifrolumab corrects innate and adaptive immune perturbations of SLE. Lupus Science, Medicine 2018;5:e000286. doi: 10.1136/lupus-2018-000286This article has been corrected since it first published. This is … ER -